New CDC guidelines stress quick treatment for H1N1

Patients who have flu-like symptoms and are having trouble breathing should get quick treatment with the antiviral drugs Tamiflu or Relenza, even before getting a flu test, U.S. officials said on Tuesday.

Experimental drug effective in killing roundworms

An experimental drug developed by scientists in China appears to be effective in killing roundworms, a parasite that lurks in the intestines and which affects nearly two billion people in tropical countries.

Flu drugs little use for children, UK study says

Children should not routinely be given flu drugs like Tamiflu since there is no clear evidence they prevent complications and potentially harmful side effects may outweigh any benefits, British researchers said on Monday.

Swine flu spreads; health officials plan vaccines

Global health officials stepped up efforts to prepare for quick vaccination against the H1N1 pandemic virus, saying on Friday it appeared now to be affecting older age groups spared earlier in the pandemic.

Sanofi says experts find Lantus studies flawed

Sanofi-Aventis said on Wednesday a group of independent experts had concluded that studies highlighting a possible link between its Lantus diabetes drug and an increased risk of cancer were flawed.


IBTimes Logo

WHO says Tamiflu-resistant H1N1

The first H1N1 infection found to be resistant to the antiviral drug Tamiflu represents an isolated case with no current implications for public health, the World Health Organization (WHO) said on Tuesday.
IBTimes Logo

Sanofi and Glaxo CEOs cast wary eye on M&A

The new bosses at Sanofi-Aventis and GlaxoSmithKline are playing a cautious acquisition game, 13 and seven months respectively after taking control of the two big European drugmakers.
IBTimes Logo

Glaxo drug delays kidney cancer progression

An experimental cancer pill from GlaxoSmithKline reduced the risk of tumour progression or death by 54 percent in advanced kidney cancer patients compared to placebo, trial results showed on Monday.